Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients

被引:35
作者
Morin, Clement [1 ]
Fardet, Laurence [2 ]
机构
[1] Hop St Camille Bry Sur Marne Val Marne, Serv Med Interne, F-94360 Bry Sur Marne, France
[2] UPEC, AP HP, Hop Henri Mondor, Serv Dermatol, F-94010 Creteil, France
关键词
Adverse events; Glucocorticoids; Online survey; TREATMENT ADHERENCE; PREVALENCE; IMPACT;
D O I
10.1007/s10067-015-2953-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite systemic glucocorticoids are widely used, risk factors for most of their adverse events and patients' beliefs about the drug are poorly known. An online survey was conducted between February and July 2013 through the website www.cortisone-info.fr. Demographic (e.g., age, gender) and therapeutic (e.g., type of prescribed glucocorticoid, duration of prescription) data were collected. Patients were further asked to answer questions about glucocorticoid-induced adverse events and their beliefs about efficacy and safety of the drug. Risk factors for adverse events and efficacy/safety beliefs were assessed using multivariate logistic regression models. Eight hundred twenty questionnaires were analyzed (women 74.3 %; median age 49 [34-62] years, median equivalent prednisone dosage 20 [10-48] mg/day). The most frequently reported adverse events were insomnia (n = 477, 58.2 %), mood disturbances (n = 411, 50.1 %), hyperphagia (n = 402, 49.0 %), and lipodystrophy (n = 387, 47.2 %). The risk of some adverse events (e.g., weight gain, easy bruising) increased with the duration of exposure while other adverse events (e.g., insomnia, mood disorders, epigastric pain) were present since the first days of exposure. The risk of hirsutism, altered wound healing, mood disturbances, weight gain, lipodystrophy, hyperphagia, and epigastric pain decreased with age. Cutaneous disorders, morphological changes, and epigastric pain were more frequently reported by women. Interestingly, patients prescribed prednisolone reported less adverse events than those prescribed prednisone. No adverse event, demographical or prescribing characteristics were associated with beliefs about efficacy while factors associated with safety concerns were age (OR: 1.2 [1.1-1.3] per 10-year increase), osteoporosis (OR: 3.3 [1.4-7.9]), easy bruising (OR: 1.6 [1.1-2.3]), insomnia (OR: 1.7 [1.2-2.4]), and weight gain (OR: 1.6 [1.1-2.2]). These results may help clinicians to adapt information speech, therapeutic education, and clinical and laboratory monitoring of patients prescribed glucocorticoid therapy.
引用
收藏
页码:2119 / 2126
页数:8
相关论文
共 18 条
[1]   Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy [J].
Arena, C. ;
Morin, A. -S. ;
Blanchon, T. ;
Hanslik, T. ;
Cabane, J. ;
Dupuy, A. ;
Fardet, L. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (04) :832-837
[2]   Population-based assessment of adverse events associated with long-term glucocorticoid use [J].
Curtis, Jeffrey R. ;
Westfall, Andrew O. ;
Allison, Jeroan ;
Bijlsma, Johannes W. ;
Freeman, Allison ;
George, Varghese ;
Kovac, Stacey H. ;
Spettell, Claire M. ;
Saag, Kenneth G. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (03) :420-426
[3]   Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids [J].
Czock, D ;
Keller, F ;
Rasche, FM ;
Häussler, U .
CLINICAL PHARMACOKINETICS, 2005, 44 (01) :61-98
[4]   Corticosteroid-induced clinical adverse events:: frequency, risk factors and patient's opinion [J].
Fardet, L. ;
Flahault, A. ;
Kettaneh, A. ;
Tiev, K. P. ;
Genereau, T. ;
Toledano, C. ;
Lebbe, C. ;
Cabane, J. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (01) :142-148
[5]   Incidence and risk factors for corticosteroid-induced lipodystrophy: A prospective study [J].
Fardet, Laurence ;
Cabane, Jean ;
Lebbe, Celeste ;
Morel, Patrice ;
Flahault, Antoine .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (04) :604-609
[6]   Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care [J].
Fardet, Laurence ;
Petersen, Irene ;
Nazareth, Irwin .
AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (05) :491-497
[7]   Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years [J].
Fardet, Laurence ;
Petersen, Irene ;
Nazareth, Irwin .
RHEUMATOLOGY, 2011, 50 (11) :1982-1990
[8]   Dose-related patterns of glucocorticoid-induced side effects [J].
Huscher, D. ;
Thiele, K. ;
Gromnica-Ihle, E. ;
Hein, G. ;
Demary, W. ;
Dreher, R. ;
Zink, A. ;
Buttgereit, F. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) :1119-1124
[9]  
Iudici M, 2014, SCAND J RHEUMATOL, V2, P1
[10]   Pharmacology of glucocorticoids [J].
Le Jeunne, Claire .
PRESSE MEDICALE, 2012, 41 (04) :370-377